Literature DB >> 23277119

Seroprevalence of East Coast fever in Central Equatoria State, South Sudan.

Wani L Marcellino1, Diaeldin A Salih, Ibrahim I Julla, Abdel Rahim M El Hussein.   

Abstract

A cross-sectional survey was conducted in 2005 in different cattle camps in Juba, Mangalla and Terekeka localities of Central Equatoria State, South Sudan. Serum samples were collected from 514 cattle of different age groups. Samples were analysed using an indirect enzyme-linked immunosorbent assay (ELISA) with commercially available polymorphic immunodominant molecule (PIM) ELISA kits. The overall serological prevalence of Theileria parva was 70.8% (364/514). The highest rate of prevalence was observed in Mangalla (91.2%) and the lowest in Juba (61.8%), with Terekeka recording 71.8%. Regarding the age groups, older cattle (over four years of age) showed a significantly higher rate of prevalence (p>0.001) than calves (below one year of age). The implications of these results in the overall epidemiology of East Coast fever in South Sudan are discussed and possible recommendations for future implementation of disease control measures are outlined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277119

Source DB:  PubMed          Journal:  Vet Ital        ISSN: 0505-401X            Impact factor:   1.101


  2 in total

1.  Prevalence and risk factors associated with Theileria parva infection in cattle in three regions of Tanzania.

Authors:  Isack I Kerario; Martin C Simuunza; Sebastian W Chenyambuga; Marja Koski; Seong-Gu Hwang; Walter Muleya
Journal:  Trop Anim Health Prod       Date:  2017-07-27       Impact factor: 1.559

2.  Tick burden and prevalence of Theileria parva infection in Tarime zebu cattle in the lake zone of Tanzania.

Authors:  Emmanuel Levillal Katamboi Laisser; Maulilio John Kipanyula; George Msalya; Robinson Hammerthon Mdegela; Esron Daniel Karimuribo; Anjello Joseph Mwilawa; Elisa Daniel Mwega; Lughano Kusiluka; Sebastian Wilson Chenyambuga
Journal:  Trop Anim Health Prod       Date:  2014-08-05       Impact factor: 1.559

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.